In the BioHarmony Drug Report Database

"Preview" Icon

Defibrotide

Defitelio (defibrotide) is an oligonucleotide pharmaceutical. Defibrotide was first approved as Defitelio on 2013-10-18. It is used to treat hepatic veno-occlusive disease in the USA. It has been approved in Europe to treat hepatic veno-occlusive disease. Defitelio’s patent is valid until 2032-06-22 (FDA).

 

Trade Name

 

Defitelio
 

Common Name

 

defibrotide
 

ChEMBL ID

 

CHEMBL2108396
 

Indication

 

hepatic veno-occlusive disease
 

Drug Class

 

Image (chem structure or protein)

Defibrotide structure rendering